News about Global Pharma

Akums Drugs Appoints Amrut Medhekar as New CDMO CEO

Akums Drugs and Pharmaceuticals Ltd. has announced the appointment of Amrut Medhekar as Chief Executive Officer of its CDMO business, approved by the company’s Board of Directors in a recent meeting.

Global Pharma | 02/09/2024 | By Aishwarya |  761

Sanyou Bio Rolls Out Comprehensive Monkeypox Product Line

Developed using Sanyou Bio's proprietary 'over-trillion innovative antibody discovery' platform, the monoclonal antibodies span multiple species, including fully human, nano, and mouse antibodies.

Global Pharma | 31/08/2024 | By Aishwarya |  543

Lupin Unveils Doxorubicin Hydrochloride Liposome Injection in US

Lupin has introduced Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials in the United States.

Global Pharma | 31/08/2024 | By Aishwarya |  704

Flagship Pioneering and Quotient Therapeutics Signs Deal with Pfizer

Pioneering Medicines, Flagship’s in-house drug discovery and development unit, is responsible for leading the strategic partnership with Pfizer, including driving the exploration process to rapidly surface potential drug development programs built on Flagship’s diverse bioplatforms and modalities.

Global Pharma | 29/08/2024 | By Aishwarya |  314

Insud Pharma Completes Acquisition of Agile Therapeutics

Insud Pharma operates throughout the value chain of the pharmaceutical industry, offering specialized knowledge in scientific research, development, manufacturing, sale and marketing of a wide range of active pharmaceutical ingredients (APIs).

Global Pharma | 28/08/2024 | By Aishwarya |  1020

Indica Labs and Paige to Expand Integrated AI for Anatomic Pathology Labs

Indica Labs has signed a non-exclusive partnership with Paige, aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP.

Global Pharma | 28/08/2024 | By Aishwarya |  658

Zuellig Pharma Signs Exclusive Distribution Deal with Regeneron to Launch Libtayo

Regeneron is a biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases.

Global Pharma | 28/08/2024 | By Aishwarya |  504

VION Biosciences Acquires Echelon Biosciences

This acquisition serves as the second investment under VION Biosciences, Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.

Global Pharma | 27/08/2024 | By Aishwarya |  740

Lupin Secures Health Canada Approval for Biosimilar Pegfilgrastim

Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim.

Global Pharma | 26/08/2024 | By Aishwarya |  474

ST Pharm Extends Partnership with Quantoom Biosciences to Advance RNA Manufacturing

By combining their respective strengths and expertise, ST Pharm and Quantoom aim to expand their global reach and provide comprehensive solutions to the RNA manufacturing market.

Global Pharma | 23/08/2024 | By Aishwarya |  658